BLISS GVS PHARMA
|
The Current P/S Ratio of BLISS GVS PHARMA is 5.35.
| Share Price | ₹467.4 | Jul 31,2026 |
| Market Cap | ₹4,963.8 Cr | |
| Sales-TTM | ₹927.1 Cr | TTM-Consolidated Results |
| Price/Sales | 5.35x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BLISS GVS PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,963.8 Cr] as on Jul 31,2026
(/) Sales [ ₹927.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 5.35x ]
Thus, for BLISS GVS PHARMA , the investors are currently willing to pay '5.35 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BLISS GVS PHARMA !
The chart below summarizes the trend in P/S Ratio of BLISS GVS PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BLISS GVS PHARMA
PS Ratio Performance Analysis for BLISS GVS PHARMA
- BLISS GVS PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 1.52x.
- BLISS GVS PHARMA 's operated at median p/e ratio of 1.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BLISS GVS PHARMA 's p/e ratio peaked in Mar2026 at 2.46x.
- BLISS GVS PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0.99x.
How does BLISS GVS PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BLISS GVS PHARMA | 927.1 | 5.35 | 4,963.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.97 | 477,312.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 20.25 | 213,879.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.34 | 194,094.0 |
| CIPLA LTD | 28,324.4 | 4.20 | 118,992.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.88 | 95,787.4 |
| MANKIND PHARMA LTD | 14,737.9 | 6.92 | 102,006.0 |
| LUPIN LTD | 27,958.0 | 3.95 | 110,374.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.14 | 112,369.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.70 | 90,872.3 |
| LAURUS LABS LTD | 7,269.6 | 13.50 | 98,126.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BLISS GVS PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.70x |
| Max industry PS | 20.25x |
| Median industry PS | 5.35x |
| Average industry PS | 7.66x |
You may also like the below Video Courses